GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Net Margin %

Changzhou Qianhong Biopharma Co (SZSE:002550) Net Margin % : 19.26% (As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Changzhou Qianhong Biopharma Co's Net Income for the three months ended in Sep. 2023 was ¥79 Mil. Changzhou Qianhong Biopharma Co's Revenue for the three months ended in Sep. 2023 was ¥409 Mil. Therefore, Changzhou Qianhong Biopharma Co's net margin for the quarter that ended in Sep. 2023 was 19.26%.

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's Net Margin % or its related term are showing as below:

SZSE:002550' s Net Margin % Range Over the Past 10 Years
Min: -7.92   Med: 16.97   Max: 35.29
Current: 11.92


SZSE:002550's Net Margin % is ranked better than
73.36% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.76 vs SZSE:002550: 11.92

Changzhou Qianhong Biopharma Co Net Margin % Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Net Margin % Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.75 15.67 -7.92 9.66 14.04

Changzhou Qianhong Biopharma Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.00 8.40 14.13 7.37 19.26

Competitive Comparison of Changzhou Qianhong Biopharma Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changzhou Qianhong Biopharma Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's Net Margin % falls into.



Changzhou Qianhong Biopharma Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Changzhou Qianhong Biopharma Co's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=323.414/2303.548
=14.04 %

Changzhou Qianhong Biopharma Co's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=78.829/409.185
=19.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changzhou Qianhong Biopharma Co  (SZSE:002550) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Changzhou Qianhong Biopharma Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines